CYBE · Cyberoptics Corp - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 | Q3 '20 | Q4 '20 | Q2 '20 | Q1 '20 | Q4 '19 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $27.57M | $24.25M | - | $27.76M | $25.20M | $20.82M | - | $16.00M | $16.43M | - |
| Cost of Revenue | $14.16M | $12.65M | - | $15.03M | $14.10M | $12.13M | - | $8.68M | $9.15M | - |
| Gross Profit | $13.41M | $11.59M | - | $12.73M | $11.11M | $8.70M | - | $7.31M | $7.28M | - |
| R&D | $3.07M | $2.93M | - | $2.65M | $2.75M | $2.40M | - | $2.18M | $2.40M | - |
| SG&A | $5.36M | $4.70M | - | $4.91M | $4.70M | $4.08M | - | $3.66M | $4.16M | - |
| Total Operating Expenses | - | - | - | - | - | - | - | - | - | - |
| D&A | - | $569.0K | - | - | - | $634.0K | - | - | $664.0K | - |
| Operating Income | $4.98M | $3.96M | - | $5.17M | $3.66M | $2.21M | - | $1.47M | $729.0K | - |
| Interest Expense | - | - | - | - | - | - | - | - | - | - |
| Income Tax | $632.0K | $458.0K | - | $514.0K | $590.0K | $409.0K | - | ($96.0K) | $149.0K | - |
| Net Income | $4.39M | $3.59M | - | $4.80M | $3.11M | $1.80M | - | $1.63M | $844.0K | - |
| EPS - Basic | $0.59 | $0.49 | - | $0.66 | $0.43 | $0.25 | - | $0.23 | $0.12 | - |
| EPS - Diluted | $0.58 | $0.47 | - | $0.63 | $0.41 | $0.24 | - | $0.22 | $0.11 | - |
Balance Sheet
| Line item | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 | Q3 '20 | Q4 '20 | Q2 '20 | Q1 '20 | Q4 '19 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $8.88M | $10.23M | $13.68M | $11.01M | $9.57M | $10.03M | $8.40M | $6.61M | $6.07M | $5.84M |
| Accounts Receivable | $28.05M | $22.27M | $19.82M | $26.91M | $22.01M | $15.91M | $14.73M | $14.88M | $14.33M | $16.06M |
| Inventory | $29.64M | $30.05M | $27.60M | $20.68M | $23.27M | $20.66M | $20.27M | $19.91M | $17.05M | $15.58M |
| Accounts Payable | $12.89M | $12.35M | $10.28M | $10.66M | $11.10M | $7.78M | $5.12M | $9.59M | $8.19M | $7.02M |
| Current Assets | $81.28M | $73.70M | $70.11M | $67.80M | $63.82M | $56.94M | $53.10M | $51.70M | $46.67M | $47.35M |
| Total Assets | $107.61M | $103.27M | $98.02M | $94.80M | $90.94M | $82.93M | $79.72M | $79.41M | $75.18M | $72.60M |
| Current Liabilities | $18.25M | $17.91M | $16.16M | $16.62M | $17.06M | $12.40M | $10.65M | $14.55M | $12.04M | $10.78M |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $20.56M | $20.47M | $18.92M | $19.53M | $20.34M | $15.78M | $14.19M | $18.45M | $16.15M | $14.28M |
| Stockholders' Equity | $87.06M | $82.80M | $79.11M | $75.28M | $70.59M | $67.16M | $65.53M | $60.95M | $59.03M | $58.32M |
| Retained Earnings | $49.54M | $45.16M | $41.56M | $38.16M | $33.36M | $30.25M | $28.81M | $25.55M | $23.91M | $23.07M |
Cash Flow
| Line item | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 | Q3 '20 | Q4 '20 | Q2 '20 | Q1 '20 | Q4 '19 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | $766.0K | - | - | - | $2.42M | - | - | $2.45M | - |
| Investing Cash Flow | - | ($4.41M) | - | - | - | ($854.0K) | - | - | ($2.33M) | - |
| Financing Cash Flow | - | $182.0K | - | - | - | $57.0K | - | - | $85.0K | - |
| CapEx | - | $491.0K | - | - | - | $650.0K | - | - | $129.0K | - |
| Free Cash Flow | - | $275.0K | - | - | - | $1.77M | - | - | $2.32M | - |
Ratios
| Metric | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 | Q3 '20 | Q4 '20 | Q2 '20 | Q1 '20 | Q4 '19 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 48.6% | 47.8% | - | 45.9% | 44.1% | 41.8% | - | 45.7% | 44.3% | - |
| Operating margin | 18.1% | 16.3% | - | 18.6% | 14.5% | 10.6% | - | 9.2% | 4.4% | - |
| EBITDA margin | - | 18.7% | - | - | - | 13.7% | - | - | 8.5% | - |
| Net margin | 15.9% | 14.8% | - | 17.3% | 12.3% | 8.6% | - | 10.2% | 5.1% | - |
| Free cash flow margin | - | 1.1% | - | - | - | 8.5% | - | - | 14.1% | - |
| FCF / Net income | - | 0.08 | - | - | - | 0.98 | - | - | 2.75 | - |
| R&D / Revenue | 11.1% | 12.1% | - | 9.5% | 10.9% | 11.5% | - | 13.6% | 14.6% | - |
| SG&A / Revenue | 19.4% | 19.4% | - | 17.7% | 18.6% | 19.6% | - | 22.9% | 25.3% | - |
| Effective tax rate | 12.6% | 11.3% | - | 9.7% | 16.0% | 18.5% | - | -6.2% | 15.0% | - |
| Return on assets | 4.1% | 3.5% | - | 5.1% | 3.4% | 2.2% | - | 2.1% | 1.1% | - |
| Return on equity | 5.0% | 4.3% | - | 6.4% | 4.4% | 2.7% | - | 2.7% | 1.4% | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 4.45 | 4.11 | 4.34 | 4.08 | 3.74 | 4.59 | 4.98 | 3.55 | 3.88 | 4.39 |
| Quick ratio | 2.83 | 2.44 | 2.63 | 2.84 | 2.38 | 2.93 | 3.08 | 2.18 | 2.46 | 2.95 |
| Cash ratio | 0.49 | 0.57 | 0.85 | 0.66 | 0.56 | 0.81 | 0.79 | 0.45 | 0.50 | 0.54 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - | - | - | - | - |
| Equity multiplier | 1.24 | 1.25 | 1.24 | 1.26 | 1.29 | 1.23 | 1.22 | 1.30 | 1.27 | 1.24 |
| Liabilities / Assets | 0.19 | 0.20 | 0.19 | 0.21 | 0.22 | 0.19 | 0.18 | 0.23 | 0.21 | 0.20 |
| Efficiency | ||||||||||
| Asset turnover | 0.26 | 0.23 | - | 0.29 | 0.28 | 0.25 | - | 0.20 | 0.22 | - |
| Inventory turnover | 0.48 | 0.42 | - | 0.73 | 0.61 | 0.59 | - | 0.44 | 0.54 | - |
| Days sales outstanding | 371d | 335d | - | 354d | 319d | 279d | - | 340d | 318d | - |
| Days inventory outstanding | 764d | 867d | - | 502d | 602d | 622d | - | 837d | 680d | - |
| Days payable outstanding | 332d | 356d | - | 259d | 287d | 234d | - | 403d | 327d | - |
| Cash conversion cycle | 803d | 846d | - | 597d | 634d | 667d | - | 774d | 672d | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 9.4% | - | - | 33.3% | 57.6% | 68.0% | - | 6.3% | 9.7% | - |
| Revenue CAGR (3y) | 22.4% | 17.4% | - | 18.5% | 16.7% | 20.7% | - | -0.8% | 11.3% | - |
| Revenue CAGR (5y) | 10.9% | 15.3% | - | 13.0% | 6.2% | 15.9% | - | 9.3% | 11.5% | - |
| Gross profit growth (YoY) | 20.7% | - | - | 46.4% | 51.9% | 57.9% | - | 11.0% | 3.7% | - |
| Operating income growth (YoY) | 36.1% | - | - | 133.9% | 148.5% | - | - | 154.4% | 27.9% | - |
| Net income growth (YoY) | 41.2% | - | - | 166.7% | 90.4% | - | - | 251.9% | 70.5% | - |
| EPS growth (YoY) | 41.5% | - | - | 162.5% | 86.4% | - | - | 266.7% | 57.1% | - |
| EPS CAGR (3y) | 113.0% | 88.7% | - | 61.3% | 60.1% | - | - | 13.6% | - | - |
| EPS CAGR (5y) | 31.1% | - | - | 31.5% | 7.2% | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | 803.9% | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 23.3% | - | 20.7% | 12.1% | 15.8% | 16.8% | 12.4% | 5.2% | 3.3% | 3.8% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2021-12-31.
Product / service
$140.97M totalInspection And Metrology Systems$42.96M · 30.5%
Mrs Based Systems$31.00M · 22.0%
High Precision3 DAnd2 DSensors$25.94M · 18.4%
Semiconductor Sensors$23.88M · 16.9%
Mrs Based Sensors$17.20M · 12.2%
Geographic
$92.77M totalCN$30.70M · 33.1%
US$15.33M · 16.5%
KR$14.81M · 16.0%
Other Europe$9.65M · 10.4%
Other Asia$7.25M · 7.8%
JP$5.14M · 5.5%
SG$4.10M · 4.4%
Other Geographic Location$3.09M · 3.3%
NL$2.70M · 2.9%
Peer comparison
Same SIC group: Optical Instruments & Lenses
Comparing CYBEROPTICS CORP against the 5 most active filers in the same SIC group.